Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 6,300 shares at $70.50 ($445K) on 2008-06-04, disclosed to the SEC on 2008-06-04.
Open-market sale of $445k ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.50 | 4 | $282 | 0.1% |
| 2 | $70.50 | 200 | $14K | 3.2% |
| 3 | $70.50 | 400 | $28K | 6.3% |
| 4 | $70.50 | 700 | $49K | 11.1% |
| 5 | $70.50 | 1,000 | $71K | 15.9% |
| 6 | $70.51 | 100 |
| $7K |
| 1.6% |
| 7 | $70.52 | 100 | $7K | 1.6% |
| 8 | $70.53 | 200 | $14K | 3.2% |
| 9 | $70.53 | 115 | $8K | 1.8% |
| 10 | $70.54 | 100 | $7K | 1.6% |
| 11 | $70.55 | 100 | $7K | 1.6% |
| 12 | $70.56 | 100 | $7K | 1.6% |
| 13 | $70.57 | 200 | $14K | 3.2% |
| 14 | $70.57 | 300 | $21K | 4.8% |
| 15 | $70.57 | 181 | $13K | 2.9% |
| 16 | $70.57 | 100 | $7K | 1.6% |
| 17 | $70.58 | 100 | $7K | 1.6% |
| 18 | $70.61 | 300 | $21K | 4.8% |
| 19 | $70.61 | 400 | $28K | 6.4% |
| 20 | $70.63 | 500 | $35K | 7.9% |
| 21 | $70.65 | 300 | $21K | 4.8% |
| 22 | $70.67 | 200 | $14K | 3.2% |
| 23 | $70.68 | 300 | $21K | 4.8% |
| 24 | $70.70 | 300 | $21K | 4.8% |
| Total | $70.57 avg | 6,300 | $445K | 100% |
| Filing → |
| ALXN | SELL | 2016-08-24 | $2.1M | — | Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |
| ALXN | SELL | 2014-11-13 | $2.9M | — | Filing → |